MEDICATION REFERENCE · REVIEW DRAFT
Saxenda: source schedule reference
Research reference only. Source-reported examples and schedules are not dosing recommendations from MGMT Research. They do not establish safety or suitability. Prescribed medication decisions belong with a licensed clinician and the current product label.
Reference notes
Saxenda is a branded liraglutide product. This page records the source schedule for review; it does not prescribe a dose or equate an MGMT research vial with the branded medicine.
The source lists daily doses of 0.6, 1.2, 1.8, 2.4, 3.0 mg. It describes increases about every week.
Saxenda is a trademark of Novo Nordisk; MGMT does not claim manufacturer affiliation.
| Vial | Diluent | Target | Volume | U-100 units |
|---|---|---|---|---|
| 10 mg | 2 mL | 600 mcg | 0.12 mL | 12 |
Source & content review 2 notes
This is an original, concise draft. Full information and numerical parity with the source is not yet established.
Open source reference ↗- Source numeric coverage is partial: selected reference values are preserved; all additional source tables and examples still require reconciliation before claiming full fidelity.
- Source is a secondary summary; current product presentation, indication and prescribing details must be reconciled with the official label before publication.
Captured source values
{
"numericalFacts": []
}